Pfizer Plans Four New Products A Year Starting In 2011

Company highlights strength of pipeline at R&D briefing, but says it will rely on a near-term licensing strategy to address “gaps.”

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet